drugset / Trial / NCT01541670
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the safety and tolerability of Anti-MIF Antibody in subjects with lupus nephritis.
Timeline
- Start
- 2011-11-28
- Primary completion
- 2012-12-31
- Completion
- 2012-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody | Protein / enzyme biologic | — | Intravenous |